Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Cited In for PMID: 30638888
3 results
Results by year
Filters applied: . Clear all
Page 1
Health Economic Evaluation of an Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable-Polymer Everolimus-Eluting Stent.
Cardiovasc Revasc Med. 2019 Sep;20(9):752-757. doi: 10.1016/j.carrev.2018.11.006. Epub 2018 Nov 20.
Cardiovasc Revasc Med. 2019.
PMID: 30638888
Free article.
Evaluation of Ultrasonic Spray Method for Application of Sirolimus-Eluting Coating on Bioresorbable Vascular Scaffolds.
Jelonek K, Jaworska J, Musiał-Kulik M, Stojko M, Włodarczyk J, Sobota M, Pastusiak M, Smola-Dmochowska A, Szewczenko J, Goldsztajn K, Dobrzyński P, Kasperczyk J.
Jelonek K, et al.
Int J Mol Sci. 2025 Aug 7;26(15):7649. doi: 10.3390/ijms26157649.
Int J Mol Sci. 2025.
PMID: 40806774
Free PMC article.
Item in Clipboard
Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents.
Bibi S, Khan A, Khan AH, Khan MN, Mushtaq S, Rashid SA.
Bibi S, et al.
Front Pharmacol. 2022 Nov 16;13:900798. doi: 10.3389/fphar.2022.900798. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36467026
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.